EP2578199A1 - Emballage unidose pour médicaments - Google Patents

Emballage unidose pour médicaments Download PDF

Info

Publication number
EP2578199A1
EP2578199A1 EP11789298.4A EP11789298A EP2578199A1 EP 2578199 A1 EP2578199 A1 EP 2578199A1 EP 11789298 A EP11789298 A EP 11789298A EP 2578199 A1 EP2578199 A1 EP 2578199A1
Authority
EP
European Patent Office
Prior art keywords
inner cavity
envelope
flap
drug
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11789298.4A
Other languages
German (de)
English (en)
Other versions
EP2578199A4 (fr
Inventor
Rosa Pardina Clar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OneDose Pharma SL
Original Assignee
OneDose Pharma SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES201030549U external-priority patent/ES1072668Y/es
Priority claimed from ES201130040U external-priority patent/ES1073777Y/es
Application filed by OneDose Pharma SL filed Critical OneDose Pharma SL
Publication of EP2578199A1 publication Critical patent/EP2578199A1/fr
Publication of EP2578199A4 publication Critical patent/EP2578199A4/fr
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2203/00—Decoration means, markings, information elements, contents indicators

Definitions

  • the invention refers to an envelope for single drug doses.
  • This invention is applicable to the field of product packing, specially packing of drugs.
  • envelopes are known which are used for the marketing of single dose drugs, generally formed starting from heat-sealable complex webs consisting in multiple layers of materials which are appropriate to provide the envelope with predetermined features which are aimed at the preservation of the properties of the drug until the moment of its administration.
  • Said layers may provide to the complex web certain specific properties, among others: mechanical resistance, opacity, impermeability and heat-sealing properties.
  • envelopes are marketed in a variable number of units within a box or container bearing multiple informations which are required for its marketing, such as the name of the product, caducity date and active components. In this way, the manufacturer of the drug has only to label the box, showing the essential information in the envelope.
  • This kind of marketing format is used in the pharmaceutic field to market powder drugs.
  • the drugs are contained within envelopes included in a main container from which they are extracted when needed, not being possible to dispense the envelopes in an individual form as the envelope does not bear the legally required informations, among others the Braille writing which is needed to allow blind people to identify the drug in question.
  • Said envelopes generally have a front surface and a back surface closed together at the sides by means of at least a longitudinal weld defining a tubular configuration, which will be closed at the upper and lower ends delimiting an inner cavity containing the drug.
  • the single dose envelopes are not appropriate as they cannot be opened or torn out in a portion of the same for the removal of the coupon which is printed in the surface of the envelope, because it is necessary to tear out the envelopes, thus violating the conservation and hygienic requirements for the drug contained inside.
  • the technical problem to be addressed is the development of a single dose envelope for drugs having appropriate characteristics to permit the incorporation of impact printings, Braille writings and other informations which are needed to permit its individualized marketing, all of it without endangering the integrity of the product contained within the envelopes and without making perforations or pores in the same which could eventually affect the correct conservation of the packed product. Furthermore, a problem has to be solved as to the capacity to remove coupons or control portions or identification parts of said envelopes preventing at the same time that the cavity to store the drugs may be altered in its integrity.
  • the envelope of the present invention is of the type of envelopes which start from a flexible sheet which includes a front surface and a rear surface laterally closed by at least one longitudinal weld and closed at the opposing ends by means of two transversal welds, defining an inner cavity containing the drug in question and has constructive peculiarities aimed at defining a surface for the incorporation of Braille writings or printings by impact without affecting the sealing characteristics of the inner cavity and the integrity of the product contained within the envelope.
  • both the front and rear surfaces of the envelope have at least at one of the ends of the inner cavity a protrusion forming a flap separate from the inner cavity by a weld area or line, forming a surface for the incorporation of Braille writings or printings by impact without affecting the sealing of the inner cavity.
  • flap out of the area which corresponds to the cavity to contain the product or drug permits to form an adequate surface to support any type of printing or marking including stamping as in the case of the Braille writing, without the risk of forming pores in the area of the envelope which defines the inner cavity and without affecting the conservation of the drug contained in the inner cavity or the integrity of the product.
  • the envelope is formed by means of a sheet which is pre-printed at least in the areas aimed at forming the front and rear surfaces of the inner cavity which permits, in combination with the definition of the above explained flap, to include in the envelope all the specifications needed for the individual marketing of the envelope containing the drug.
  • said flap has at least a flat portion forming the surface aimed at the incorporation of Braille writings or for impact printing, so that these writings may be readable by touch, by blind persons. It has to be mentioned that the protrusions on the front and rear surfaces forming the flap may be simply superimposed and laterally adapted or secured to each other by heat-sealing, gluing or any other securing means, as these do not affect the essence of the invention.
  • the envelope has a peculiarity which consists in having in the flap and in an area near to the inner cavity, a precut line for tearing and separating the portion of the flap incorporating the identification of the drug, preserving the integrity of the inner cavity of the envelope.
  • the envelope (1) has a front surface (11) and a rear surface (12) formed by heat-sealable sheets secured and closed at its sides by means of longitudinal welds (13) and at the opposed ends by means of transversal welds (14) delimitating an inner cavity (15) aimed at containing the drug, which has been represented in this case by capsules (2).
  • the front and rear surfaces (11, 12) have at one of the ends of the inner cavity (15) protrusions forming a flap (16) separate from the inner cavity (15) by a transversal line or area of welding (14) which forms a surface for the incorporation of Braille writings (3) or impact printings, although in other embodiments, the printings may be ink printings.
  • the protrusions of the front and rear surfaces (11, 12) forming the flap (16) are superimposed and secured by heat-sealing in all of its extension showing a flat portion (17), that is, a portion without the typical serration profile of the heat-sealed union lines, precisely forming said flat portion (17) the surface aimed at the incorporation of Braille writings (3) or impact printings.
  • a flat portion (17) that is, a portion without the typical serration profile of the heat-sealed union lines, precisely forming said flat portion (17) the surface aimed at the incorporation of Braille writings (3) or impact printings.
  • the protrusions of the front and rear surfaces (11, 12) forming the flap (16) are superimposed and secured by heat-sealing only at the longitudinal welding lines (13) of the side borders and by the line or area of transversal welding (14) which separates said surfaces from the inner cavity (15) of the envelope.
  • the flap (16) shows as well a flat surface (16) permitting the definition and subsequent reading by touch of the Braille writings (3) or impact printings.
  • the flaps (16) define a surface appropriate for the definition of the writings (3) made by means of reliefs or by impact printing without the risk of harming the area which corresponds to the inner cavity (15) or the drugs themselves contained therein.
  • the envelope (1) is formed by means of a pre-printed heat-sealable sheet, which permits the envelope to incorporate, apart from the Braille writings (3) or impact printings defined in the flap (16), at least on one of its front and rear surfaces (11, 12) the specifications (4) which are necessary for the individual marketing of the envelope (1).
  • FIG. 7 a further alternative embodiment of the envelope (1) has been shown which comprises in an area near to the inner cavity (15) of the flap (16) a precut line (5) for the tearing and separation of the part of the flap (16) incorporating the information concerning the drug, without harming said inner cavity (15).
  • the precut line (5) is located in an intermediate area of the transversal weld (14) separating the flap (16) from the inner cavity (15), so that after the precut line (5) has been torn out and the flap (16) has been separated, the inner cavity (15) keeps sealed along its periphery, all as has been shown in figure 7 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Composite Materials (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Packages (AREA)
  • Making Paper Articles (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
EP20110789298 2010-05-31 2011-03-25 Emballage unidose pour médicaments Withdrawn EP2578199A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES201030549U ES1072668Y (es) 2010-05-31 2010-05-31 Sobre monodosis para medicamentos
ES201130040U ES1073777Y (es) 2011-01-19 2011-01-19 Sobre monodosis mejorado para medicamentos
PCT/ES2011/070205 WO2011151492A1 (fr) 2010-05-31 2011-03-25 Emballage unidose pour médicaments

Publications (2)

Publication Number Publication Date
EP2578199A1 true EP2578199A1 (fr) 2013-04-10
EP2578199A4 EP2578199A4 (fr) 2015-04-22

Family

ID=45066218

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20110789298 Withdrawn EP2578199A4 (fr) 2010-05-31 2011-03-25 Emballage unidose pour médicaments

Country Status (5)

Country Link
US (1) US20130068828A1 (fr)
EP (1) EP2578199A4 (fr)
BR (1) BR112012030612A2 (fr)
MX (1) MX2012013866A (fr)
WO (1) WO2011151492A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107696730B (zh) * 2016-08-08 2019-12-20 外贸无锡印刷股份有限公司 一种药盒盲文防混方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3358824A (en) * 1965-08-03 1967-12-19 Hoffmann La Roche Dispensing of pharmaceuticals
US6199698B1 (en) * 1999-12-03 2001-03-13 Alusuisse Technology & Management, Ltd. Pharmaceutical packaging with separation means
WO2005115843A1 (fr) * 2004-05-24 2005-12-08 Transdermal Technology & Systems (Tts) Limited Procede de formage-remplissage-fermeture
US20060157370A1 (en) * 2004-03-11 2006-07-20 Thuesen Marcus L Pouch containers having advertising media and methods for their dissemination
US20080107781A1 (en) * 2006-11-06 2008-05-08 Christopher Carroll Food container

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1816542A (en) * 1928-02-17 1931-07-28 Winthrop Chem Co Inc Dispensing device for small commodities
US2877893A (en) * 1957-04-16 1959-03-17 Ivers Lee Co Package with removable indiciabearing sheet
US2997166A (en) * 1959-06-16 1961-08-22 Pratt Mfg Corp Packages for flat articles such as surgical supplies and method of wrapping such articles
US3014638A (en) * 1960-03-14 1961-12-26 Farley Preston Package construction
US3316839A (en) * 1966-04-20 1967-05-02 Addressograph Multigraph Ink package and supply system for duplicating machines
US3497982A (en) * 1968-11-22 1970-03-03 Ciba Geigy Corp Package and method for dispensing of pharmaceutical preparations
US3554435A (en) * 1969-01-16 1971-01-12 Milprint Inc Pouch with reinforced edge
US3873735A (en) * 1971-05-04 1975-03-25 Nabisco Inc Food package for heating and venting
US3915212A (en) * 1973-12-10 1975-10-28 Abbott Lab Flexible medical fluid container having a combined fill and administration port and reinforced hanger
US4240552A (en) * 1979-03-12 1980-12-23 C. R. Laurence Co., Inc. Display package
US4709397A (en) * 1985-12-24 1987-11-24 John H. Harland Company Tamper-evident envelope with indicia-forming cohesive layers
US4972657A (en) * 1988-01-11 1990-11-27 Rna, Incorporated Method of packaging medication for controlled dispensing
US5064071A (en) * 1990-04-05 1991-11-12 Kerfoot Corporation Container apparatus
US5210975A (en) * 1992-01-17 1993-05-18 Beckerman Jerold L Seed-sprouting kit
US5390796A (en) * 1992-10-02 1995-02-21 Kerfoot, Jr.; Franklin W. Envelope apparatus for dispensing medications from drug files
US5377836A (en) * 1993-10-04 1995-01-03 United Industrial Trading Corporation Blister card display package
CA2129599C (fr) * 1994-04-27 2000-05-16 Joshua Lapsker Distributeur d'echantillons et bon de commande combines
US5887410A (en) * 1995-03-01 1999-03-30 International Beauty Network, Inc Method of molding an packaging of a novelty soap
US5609253A (en) * 1995-06-30 1997-03-11 Ssi Photo I.D. Data card security display packaging
US5702559A (en) * 1995-07-13 1997-12-30 B&H Manufacturing Company, Inc. Method and apparatus for applying a tactilely distinguishable marking on an article
US5791478A (en) * 1997-12-05 1998-08-11 Multi-Comp, Inc. Package assembly for dispensing pharmaceutical medications
US6758341B1 (en) * 1997-12-17 2004-07-06 Livingston Seed, Inc. Seed envelope and method of packaging seed
US6951353B2 (en) * 1999-05-29 2005-10-04 Nancy Kozlowski Medication record system and dispenser
WO2003092357A1 (fr) * 2002-05-03 2003-11-13 Florence Poret Carnet pour germination et transplantation de plantes
US7726481B2 (en) * 2002-08-29 2010-06-01 Colbert Packaging Corporation Display chamber packaging container and method for making
EP1800645A1 (fr) * 2005-12-21 2007-06-27 Körber AG Emballage pour produits médicaux et autres
US7506761B2 (en) * 2006-02-24 2009-03-24 Navajo Manufacturing Company, Inc. Drug display card
US20100172604A1 (en) * 2009-01-06 2010-07-08 Printpack Illinois, Inc. Reclosable Container with Resealable Flexible Cover and Method for Manufacturing the Same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3358824A (en) * 1965-08-03 1967-12-19 Hoffmann La Roche Dispensing of pharmaceuticals
US6199698B1 (en) * 1999-12-03 2001-03-13 Alusuisse Technology & Management, Ltd. Pharmaceutical packaging with separation means
US20060157370A1 (en) * 2004-03-11 2006-07-20 Thuesen Marcus L Pouch containers having advertising media and methods for their dissemination
WO2005115843A1 (fr) * 2004-05-24 2005-12-08 Transdermal Technology & Systems (Tts) Limited Procede de formage-remplissage-fermeture
US20080107781A1 (en) * 2006-11-06 2008-05-08 Christopher Carroll Food container

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2011151492A1 *

Also Published As

Publication number Publication date
EP2578199A4 (fr) 2015-04-22
US20130068828A1 (en) 2013-03-21
BR112012030612A2 (pt) 2016-08-16
MX2012013866A (es) 2013-02-07
WO2011151492A1 (fr) 2011-12-08

Similar Documents

Publication Publication Date Title
RU2692434C2 (ru) Тара с настраиваемым механизмом для открывания и закрывания внутренней упаковки
US5390796A (en) Envelope apparatus for dispensing medications from drug files
EP2471725A1 (fr) Conditionnement avec couche de couvercle refermable
KR20120135482A (ko) 경구 의약을 위한 투여방법 및 패키징
BRPI0616106A2 (pt) cartolina para conter uma pluralidade de artigos, e matriz para formação de uma cartolina
WO2005066035A1 (fr) Cartouche de paquets de cigarettes comprenant une feuille promotionnelle separable
EP3186168B1 (fr) Emballage à récipient avec partie amovible
US20150239603A1 (en) Container for a health product housing inside an information leaflet and a method for making the container
ES2290017T3 (es) Paquetes de cigarrillos.
JP4261371B2 (ja) タバコ小箱を包装する方法および斯かる方法を実施するための包装材料シート
JP2004524071A (ja) ブリスタパックを採用する包装手段
BRPI0709857A2 (pt) embalagem, matriz, mÉtodo de conformaÇço de uma matriz para formar uma embalagem, e mÉtodo para troca de ar em uma embalagem fechada
US20100288669A1 (en) Packaging unit
US7971711B2 (en) Folded and sealed coupon insertable in packs containing tobacco products, and a blank from which to fashion the coupon
EP0818393A1 (fr) Carton pour médicaments avec rabats supplémentaires portant des informations
EP2578199A1 (fr) Emballage unidose pour médicaments
RU2682343C2 (ru) Контейнер с оберткой с отрывным язычком
CN104554844A (zh) 用于生产药片包装盒的设备
BR112021003406A2 (pt) embalagem para produtos da indústria do tabaco e método de embalar produtos da indústria do tabaco
JP7553043B2 (ja) 包装箱
JP4894633B2 (ja) 紙箱
BR102012013529A2 (pt) Embalagens retornáveis para serviços de correio
NL2029009B1 (en) Sheet for use in pill packages, and pouch formed from a sheet
WO2009127736A1 (fr) Emballage pour produit médical
JP7162454B2 (ja) 包装用箱

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20121123

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20150323

RIC1 Information provided on ipc code assigned before grant

Ipc: B65D 75/30 20060101ALI20150317BHEP

Ipc: A61J 1/03 20060101AFI20150317BHEP

17Q First examination report despatched

Effective date: 20160523

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20161005